Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-10-14
1988-09-20
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514326, 514327, 514330, 514332, 514335, 514336, 514346, 514350, 514356, 546194, 546203, 546204, 546213, 546216, 546227, 546261, 546263, 546284, 546298, 546316, 546322, A61K 31445, A61K 3144, C07D21178, C07D21160
Patent
active
047726156
ABSTRACT:
Analogs of nipecotic acid are the novel compounds of the present invention. The analogs are GABA uptake inhibitors for use to treat epilepsy and, thus, the invention is also pharmaceutical compositions and methods of use therefor.
REFERENCES:
R. L. Krall, et al., Epilepsia, 19:409, (1978).
W. S. Schwark & W. Loscher, "Comparison of the Anticonvulsant Effects of Two Novel GABA Uptake Inhibitors & Diazepam in Amygdaloid Kindled Rats", Naunyn Schmiedeberg's Arch. Pharmacol., 329:367-71, (1985).
EP Search Report attached.
Bjorkman Dale A.
Rotman Alan L.
Thierstein Joan
Warner-Lambert & Company
LandOfFree
Various N-substituted 3-piperidine carboxylic acids or N-substit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Various N-substituted 3-piperidine carboxylic acids or N-substit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Various N-substituted 3-piperidine carboxylic acids or N-substit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1748776